Bone marrow derived mesenchymal stem cells suppress diethylnitrosamine induced liver cirrhosis in rats
E.AboEl-Magd, Y., G.Mohamed, M., Raafat, N., Abdelhamid, M., A.El-Turky, H. (2019). Bone marrow derived mesenchymal stem cells suppress diethylnitrosamine induced liver cirrhosis in rats. EKB Journal Management System, 15(1), 75-84. doi: 10.21608/blj.2019.47565
Yousry E.AboEl-Magd; Mohamed G.Mohamed; Nermin Raafat; Moustafa Salaheldin Abdelhamid; Hagar A.El-Turky. "Bone marrow derived mesenchymal stem cells suppress diethylnitrosamine induced liver cirrhosis in rats". EKB Journal Management System, 15, 1, 2019, 75-84. doi: 10.21608/blj.2019.47565
E.AboEl-Magd, Y., G.Mohamed, M., Raafat, N., Abdelhamid, M., A.El-Turky, H. (2019). 'Bone marrow derived mesenchymal stem cells suppress diethylnitrosamine induced liver cirrhosis in rats', EKB Journal Management System, 15(1), pp. 75-84. doi: 10.21608/blj.2019.47565
E.AboEl-Magd, Y., G.Mohamed, M., Raafat, N., Abdelhamid, M., A.El-Turky, H. Bone marrow derived mesenchymal stem cells suppress diethylnitrosamine induced liver cirrhosis in rats. EKB Journal Management System, 2019; 15(1): 75-84. doi: 10.21608/blj.2019.47565

Bone marrow derived mesenchymal stem cells suppress diethylnitrosamine induced liver cirrhosis in rats

Biochemistry Letters
Article 6, Volume 15, Issue 1, 2019, Page 75-84  XML PDF (840.66 K)
Document Type: Original Article
DOI: 10.21608/blj.2019.47565
View on SCiNiTO View on SCiNiTO
Authors
Yousry E.AboEl-Magd1; Mohamed G.Mohamed2; Nermin Raafat1; Moustafa Salaheldin Abdelhamid3; Hagar A.El-Turky4
1Medical Biochemistry and Molecular Biology Department, Faculty of medicine,Zagazig University, Zagazig, Egypt.
2Chemistry Department, Faculty of science, Zagazig University, Zagazig, Egypt.
3Biochemistry Division, Chemistry, Faculty of science, Zagazig university
4Biochemistry Division, Chemistry Department, Faculty of science, Zagazig University, Zagazig, Egypt.
Abstract
Aim: The present study was designed to explore the ability of bone marrow derived mesenchymal stem cells (BM-MSCs) to repair diethylnitrosamine (DEN)-induced liver cirrhosis (DILC) in rats. Materials and methods: Sixty male rats were divided into four groups (15 rats per group), the rats of the first group received saline, and the rats of the other three groups received DEN in drinking water. After thirty days, the rats of the third and fourth groups received 1.5x106 and 2x106 MSC infusions ,respectively. Liver function tests were estimated in serum of rats in all groups. The expression of albumin (Alb) and cytokeratin-18 (CK-18) genes were detected by reverse transcription-polymerase chain reaction (RT-PCR). Histopathological examination of liver tissue was performed. Results: Administration of BM-MSC of both doses (1.5x106 and 2x106 cells) into rats with DILC resulted in ameliorating liver functions and histopathological features compared to that received DEN only. RT-PCR analysis revealed that the expression of albumin gene increased, while CK-18 decreased in liver tissue of rats with DILC which received 2x106 BM-MSCs compared to DEN control group. Conclusion: BM-MSCs suppressed DEN-induced liver cirrhosis in rats as indicated by up regulation of albumin and CK-18 genes, as well as improvement of liver functions and architecture. 
Statistics
Article View: 365
PDF Download: 275